Burning Rock Biotech (BNR) Share-based Compensation (2020 - 2025)

Burning Rock Biotech's Share-based Compensation history runs 6 years deep, the most recent figure standing at $625375.4 for Q1 2025.

• In Q1 2025, Share-based Compensation fell 93.55% year-over-year to $625375.4; the TTM figure through Mar 2025 stood at $12.6 million (down 64.27% YoY), while the FY2025 annual figure was $2.0 million, down 90.69% from the prior year.
• Share-based Compensation was $625375.4 for Q1 2025 at Burning Rock Biotech, down from $1.1 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $13.1 million in Q1 2021 to a low of $625375.4 in Q1 2025.
• Historically, Share-based Compensation has averaged $8.9 million across 5 years, with a median of $9.9 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Share-based Compensation surged 2090.46% in 2021, then plunged 93.55% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $9.5 million in 2021, then surged by 35.7% to $12.9 million in 2022, then decreased by 23.11% to $9.9 million in 2023, then slumped by 88.74% to $1.1 million in 2024, then tumbled by 43.93% to $625375.4 in 2025.
• The last three Share-based Compensation figures came in at $625375.4 (Q1 2025), $1.1 million (Q4 2024), and $1.4 million (Q3 2024), per Business Quant data.